In contrast to incomplete/undifferentiated forms of lupus, preclinical SLE typically refers to individuals with serological evidence of autoimmunity (e.g., positivity for ANA and/or other autoantibodies), without any evident clinical symptoms. This evidence concerns the gene BTG3 and Autoimmunity.